PriveBio is a precision medicine biotech focused on developing first-in-class therapeutics targeting metabolic dysfunction and fibro-inflammation in cardiorenal metabolic diseases (obesity, heart failure, NASH/MASH, and chronic kidney diseases), prosecuting validated targets from human proteo-genomi... Read more
This company has no teams yet
This company has no offices yet
Revvity
15 followers
NHS Grampian
2 followers
Merck
348 followers
Zydus Group
15 followers
Eugia Pharma Specialities Ltd
2 followers
Pfizer
754 followers
DynamiCure Biotechnology
1 follower
Amgen
348 followers
Pierre Fabre
27 followers
AstraZeneca India
2 followers
Octapharma France
2 followers
Xilio Therapeutics
2 followers